4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market
Holding FDMT?
Track your performance easily

4D Molecular Therapeutics (FDMT) Ownership - Who Owns 4D Molecular Therapeutics?

280 Followers

4D Molecular Therapeutics (FDMT) Ownership Overview

13.09%12.60%6.38%12.85%55.08%
13.09% Insiders
6.38% Other Institutional Investors
12.85% ETFs
55.08% Public Companies and
Individual Investors
The ownership structure of 4D Molecular Therapeutics (FDMT) stock is a mix of institutional, retail, and individual investors. Approximately 31.83% of the company’s stock is owned by Institutional Investors, 13.09% is owned by Insiders, and 55.08% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Jan 05, 2024
xxxxxxxxxxxxx
$10546200

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,098,211Institution9.81%41,270,018
4,247,914Insider8.17%34,386,864
2,934,914Institution5.65%23,758,129
2,493,237Institution4.80%20,182,754
2,462,587Institution4.74%19,934,642
2,033,069Insider4.70%16,457,694
2,031,999Institution3.91%16,449,032
1,153,437Institution2.22%9,337,073
1,011,350Institution1.95%8,186,878
881,157Institution1.70%7,132,966

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,031,999Institution3.91%16,449,032
1,011,350Institution1.95%8,186,878
881,157Institution1.70%7,132,966
567,184Institution1.09%4,591,354
423,953Institution0.82%3,431,900
308,490Institution0.59%2,497,227
248,209Institution0.48%2,009,252
230,435Institution0.44%1,865,371
182,230Institution0.35%1,475,152
135,933Institution0.26%1,100,378

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,537,368Institution2.96%16,618,948
1,308,552Institution2.52%10,592,728
996,421Institution1.92%7,981,332
589,154Institution1.13%6,368,755
231,588Institution0.45%2,503,466
308,451Institution0.59%2,496,911
287,489Institution0.55%2,327,223
181,783Institution0.35%1,456,082
167,277Institution0.32%1,354,107
115,241Institution0.22%932,876

FAQ

Who Owns 4D Molecular Therapeutics (FDMT)?
According to the latest TipRanks data, approximately 6.38% of the company's stock is held by institutional investors, 13.09% is held by insiders, and 55.08% is held by retail investors.
    What percentage of 4D Molecular Therapeutics (FDMT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 6.38% of 4D Molecular Therapeutics (FDMT) stock is held by institutional investors.
      What percentage of 4D Molecular Therapeutics (FDMT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 55.08% of 4D Molecular Therapeutics (FDMT) stock is held by retail investors.
        Who owns the most shares of 4D Molecular Therapeutics (FDMT)?
        Peter Kolchinsky owns the most shares of 4D Molecular Therapeutics (FDMT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis